Free Trial

Xylem (NYSE:XYL) Sets New 12-Month High - Should You Buy?

Xylem logo with Business Services background

Key Points

  • Xylem Inc. (NYSE:XYL) reached a new 52-week high of $145.70 and has a current price consensus target of $152.33.
  • Wall Street analysts have shown increased confidence in Xylem, with ratings upgraded to "strong-buy" and "overweight," accompanied by increasing price targets from various firms.
  • The company reported $1.26 EPS, exceeding expectations, and announced a quarterly dividend of $0.40, resulting in an annualized yield of 1.1%.
  • Five stocks to consider instead of Xylem.

Xylem Inc. (NYSE:XYL - Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $145.70 and last traded at $145.22, with a volume of 109262 shares traded. The stock had previously closed at $143.95.

Wall Street Analysts Forecast Growth

XYL has been the subject of a number of research analyst reports. Mizuho upped their price target on Xylem from $125.00 to $140.00 and gave the company a "neutral" rating in a report on Friday, September 12th. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Zacks Research upgraded shares of Xylem from a "hold" rating to a "strong-buy" rating in a research note on Monday, September 22nd. Barclays initiated coverage on shares of Xylem in a research note on Friday, September 19th. They issued an "overweight" rating and a $165.00 price objective for the company. Finally, TD Cowen raised their target price on shares of Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a research report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $152.33.

Get Our Latest Stock Report on XYL

Xylem Stock Performance

The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. The stock has a fifty day moving average price of $140.60 and a 200-day moving average price of $128.78. The firm has a market cap of $35.67 billion, a price-to-earnings ratio of 38.06, a price-to-earnings-growth ratio of 2.47 and a beta of 1.09.

Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business's revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the business earned $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, analysts expect that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were paid a $0.40 dividend. The ex-dividend date was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem's payout ratio is 41.56%.

Insiders Place Their Bets

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares in the company, valued at approximately $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.27% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Xylem

A number of large investors have recently made changes to their positions in XYL. AFG Fiduciary Services Limited Partnership acquired a new stake in shares of Xylem during the 2nd quarter valued at approximately $275,000. IFM Investors Pty Ltd raised its holdings in Xylem by 11.6% during the second quarter. IFM Investors Pty Ltd now owns 54,073 shares of the industrial products company's stock worth $6,995,000 after purchasing an additional 5,617 shares during the last quarter. Dynamic Advisor Solutions LLC purchased a new stake in Xylem during the first quarter worth $694,000. Farther Finance Advisors LLC grew its holdings in Xylem by 30.4% in the first quarter. Farther Finance Advisors LLC now owns 1,797 shares of the industrial products company's stock valued at $215,000 after purchasing an additional 419 shares during the last quarter. Finally, BROOKFIELD Corp ON increased its position in shares of Xylem by 26.5% in the first quarter. BROOKFIELD Corp ON now owns 16,375 shares of the industrial products company's stock valued at $1,956,000 after buying an additional 3,430 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.